维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Avignon A"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Insulin sensitivity and stress显示文摘	Avignon A Monnier L	2001	Diabetes Metab2001，27，22：	1
2	Carbon flux distribution in antibiotic-producing chemostat cultures of Streptomyces lividans 显示文摘	Avignone RC White J Kuiper A	2002	Metab Eng2002，4，：	1
3	Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients显示文摘	Avignon A Sultan A Piot C		0，，：	1
4	Magnetic moment formation in quantum point contacts显示文摘	CORNAGLIA P S BALSEIRO C A AVIGNON M	2005	Physical Review B2005，71，2：	1
5	PKC-B inhibition: a new therapeutic approach for diabetic complications? 显示文摘	Avignon A Sultan A	2006	Diabetes Metab2006，32，3：	1
6	Insulin sensitivity and stress 显示文摘	Avignon A Monnier L	2001	Diabe- tes Metab2001，27，22：	1
7	Nonfasting plasma glucose is a better marker of diabetic control than fasting glucose in type 2 diabetes显示文摘	AVIGNON A RADANCEANU A MONLNIER L	1997	Diabetes Care1997，20，：	1
8	Emission inventory: An urban public policy instrument and benchmark 显示文摘	Avignon A D Carloni F A Rovere E L L et a\|	2010	Energy Policy2010，38，9：	1
9	Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients显示文摘	Avignon A Sultan A Piot C	2005	Diabetes Care2005，28，9：	1
10	Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients显示文摘	Avignon A Sultan A Piot C	2005	Diabetes Care2005，28，9：	1
11	Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes显示文摘	Avignon A Radauceanu A Monnier L		0，，：	1
12	Emission inventory: an urban public policy instrument and benchmark 显示文摘	D'Avignon A Carloni F A Rovere E L L	2010	Energy Policy2010，38，9：	1
13	PKC-B inhibition:a new therapeutic approach for diabetic complication?显示文摘	Avignon A Sultan A	2006	Diabetes Metab2006，32，3：	1
14	Nonfasting Plasma glucose is a bet- ter marker of diabetic control than fasting plasma glucose in type 2 dia- betes显示文摘	Avignon A Radauceanu A Monnier L	1997	Diabetes Care1997，20，：	1
15	Osteoprotegerin is associated with silent coronary artery disease in high risk but asymptomatic type 2 dia-betic patients显示文摘	Avignon A Sultan A Piot C		0，，09：	1
16	Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients显示文摘	Avignon A Sultan A Piot C		0，，：	1
17	NMR identification of heavy metal-binding sites in a synthetic zinc finger peptide: toxicological implications for the interactions of xenobiotic metals with zinc finger proteins显示文摘	Razmiafshari M Kao J Avignon A	2001	Toxieol Appl Pharmacol2001，172，1：	1
18	Structure elucidation of thioketone analogues of sildenafil detected as adulterants in herbal aphrodisiacs显示文摘	Reepmeyer J C d'Avignon D A	2009	Pharmaceutical and Biomedical Analysis2009，49，1：	1
19	-Cyclodextrin dimers as potential tumorpretargeting agents显示文摘	Edwards WB Reichert DE d'Avignon A	2001	Chem Commun2001，，14：	1
20	3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation byeosinophil peroxidase: potential markers for eosinophil-dependenttissue injury in vivo显示文摘	Wu W Chen Y d’Avignon A	1999	Biochemistry1999，38，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示